Stephanie Bova

Stephanie Bova is a seasoned executive in the pharmaceutical sector, currently serving as Corporate Vice President and Digital Transformation Officer for Drug Development at Novo Nordisk since August 2023. Bova is also a Non-Executive Board Member at Adragos Pharma and has previously held notable positions, including Head of Digital Strategy and Innovation at BD and Vice President roles at Novartis, where significant contributions were made in redefining drug development and enhancing success rates in oncology. With extensive experience in digital health and venture capital, Bova co-founded Takeda’s Digital Accelerator and has served on the boards of various companies focused on innovation in healthcare. Bova holds an MBA from the University of Maryland Global Campus, an executive education certificate in Data Science from Johns Hopkins University, and a Bachelor of Arts in International Studies from the University at Buffalo, complemented by a minor in Japanese Language and Literature.